Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech. Have the good days finally come to an end ...

A BioNTech spokesperson downplayed the news, insisting that the two companies remain “close” and have a “strong collaboration ...

Pfizer has sold a significant portion of its stake in German drugmaker BioNTech SE, a more than five years after the two ...

SC lawmakers advanced a bill that would require a disclaimer for COVID-19 vaccinations. Physicians have broadly encouraged ...

A proposed bill in South Carolina is stirring new controversy over the COVID-19 vaccine. If passed, the bill would require doctors and pharmacists to provide a ...

BioNTech (NasdaqGS:BNTX) shares caught investors’ attention after Pfizer revealed plans to sell its remaining stake in the company through an overnight block trade. This announcement prompted a wave ...

As a damning report finds all four UK governments failed to appreciate the scale of the threat posed by COVID-19 or the ...

Pfizer sell 508M stake in BioNTech through an overnight block trade, marking its exit from the COVID-19 vaccine partner's equity.

A UK study reveals COVID-19 poses greater long-term cardiac and clotting risks in children compared to minimal vaccine ...

Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than ​five years after both ...

Move marks shift after years of mRNA collaboration that produced COVID-19 vaccine.

The Metsera buyout brings multiple obesity and cardiometabolic drug candidates into Pfizer’s pipeline, including a GLP-1 ...